CCNE
CNB Financial Corporation
CCNE has the edge over JPM overall, supported by stronger fundamentals and stronger valuation.
JPM
JPMorgan Chase & Co.
JPM has slightly lower modeled downside risk, despite its lower overall score.
CCNE Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| N/A | |
| N/A |
CCNE's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like CCNE.
JPM Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| N/A | |
| N/A |
JPM's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like JPM.
CCNE PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 6.8x | $22.90 | -36% |
| Fair | 9.4x | $31.75 | -11% |
| Forward | 9.8x | $35.64 | — |
| Current | 11x | $35.64 | — |
| Expensive | 12x | $41.88 | +17% |
Historical ranges are pointers, not guarantees.
CCNE's PE is in its expensive range at 11x. If earnings grow as analysts expect, today's price would be 9.8x next year's earnings, in its fair range.
JPM PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 9.7x | $231 | -33% |
| Fair | 12x | $287 | -16% |
| Current | 14x | $343 | — |
| Forward | 14x | $343 | — |
| Expensive | 15x | $361 | +5.2% |
Historical ranges are pointers, not guarantees.
JPM has the edge over CCNE in the historical PE scenario, which offers more potential upside but is not a forecast.
CCNE Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Growth | |
| Growth | |
| Improving | |
| Limited | |
| High |
CCNE has the edge over JPM on the outlook, with more favorable valuation expectations.
JPM Forward outlook
| Metric | Outlook |
|---|---|
| Stable | |
| Growth | |
| Growth | |
| Improving | |
| Limited | |
| Moderate |
Analysts expect earnings and revenue growth for JPM, with profitability improving.
CCNE Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $3.64 | +8.2% |
| Q3 2026 | $3.36 | +68% |
| Q2 2026 | $2.67 | +12% |
| Q1 2026 | $2.37 | +1.3% |
| Q4 2025 | $1.99 | -17% |
| Q3 2025 | $2.00 | -14% |
| Q2 2025 | $2.39 | +3% |
| Q1 2025 | $2.34 | -1.3% |
| Q4 2024 | $2.39 | -6.3% |
CCNE earned $3.36 per share over the past year, up 68% from the year before.
JPM Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $24.99 | +4.8% |
| Q3 2026 | $23.85 | +18% |
| Q2 2026 | $23.35 | +20% |
| Q1 2026 | $20.89 | +2.5% |
| Q4 2025 | $20.02 | +1.4% |
| Q3 2025 | $20.20 | +12% |
| Q2 2025 | $19.50 | +8.7% |
| Q1 2025 | $20.38 | +23% |
| Q4 2024 | $19.75 | +22% |
JPM has the edge over CCNE on earnings, with more consistent year-over-year improvement.
CCNE Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $87.8M | +13% |
| Q2 2026 | $87.6M | +43% |
| Q1 2026 | $83.3M | +46% |
| Q4 2025 | $86.4M | +45% |
| Q3 2025 | $77.7M | +33% |
| Q2 2025 | $61.2M | +12% |
| Q1 2025 | $56.9M | +5.1% |
| Q4 2024 | $59.4M | +4.5% |
CCNE has the edge over JPM on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 38% | +26 points |
| Q2 2026 | 40% | +12 points |
| Q1 2026 | 40% | +15 points |
| Q4 2025 | 48% | +17 points |
| Q3 2025 | 12% | -18 points |
| Q2 2025 | 28% | -1.1 points |
| Q1 2025 | 25% | -3.3 points |
| Q4 2024 | 31% | +1.2 points |
CCNE's operating margin was 38% last quarter, up 26 points from the same quarter a year ago.
JPM Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $50.2B | +8.1% |
| Q2 2026 | $57.3B | +28% |
| Q1 2026 | $49.8B | +10% |
| Q4 2025 | $45.8B | +7.1% |
| Q3 2025 | $46.4B | +8.8% |
| Q2 2025 | $44.9B | -11% |
| Q1 2025 | $45.3B | +8.1% |
| Q4 2024 | $42.8B | +11% |
JPM's revenue has grown year over year for five quarters in a row: $50.2B last quarter, up 8.1% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 40% | -0.2 points |
| Q2 2026 | 48% | +7.3 points |
| Q1 2026 | 41% | +0.5 points |
| Q4 2025 | 37% | -3.2 points |
| Q3 2025 | 40% | +0.6 points |
| Q2 2025 | 41% | -6 points |
| Q1 2025 | 41% | -0.6 points |
| Q4 2024 | 41% | +11 points |
JPM has the edge over CCNE on profitability, with a higher operating margin.
CCNE Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $3.6M | -26% |
| Q2 2026 | $36M | +101% |
| Q1 2026 | $18.8M | +91% |
| Q4 2025 | $26M | +38% |
| Q3 2025 | $4.9M | -78% |
| Q2 2025 | $17.9M | +332% |
| Q1 2025 | $9.9M | -1.4% |
| Q4 2024 | $18.8M | +19% |
CCNE has the edge over JPM on cash generation, producing positive trailing cash flow while its opponent burns cash.
JPM Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $33.2B | +$78.4B |
| Q2 2026 | -$25.3B | -186% |
| Q1 2026 | -$211.8B | +$40.1B |
| Q4 2025 | $119.7B | -19% |
| Q3 2025 | -$45.2B | +$28.9B |
| Q2 2025 | $29.5B | -23% |
| Q1 2025 | -$251.8B | -$97.7B |
| Q4 2024 | $147.8B | +145% |
JPM's free cash flow was −$84.2B over the past year, against −$120B the year before. Free cash flow isn't a meaningful measure for financial services companies like JPM.
CCNE Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.1% | +41K shares |
| 1 year | +8.3% | +2.3M shares |
| 3 years | +41% | +8.6M shares |
| 5 years | +75% | +12.7M shares |
| Available history | +95% | +14.4M shares |
CCNE has 30M diluted shares, up 8.3% from a year ago.
JPM Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.4% | -11.2M shares |
| 1 year | -3.1% | -84.6M shares |
| 3 years | -8.5% | -249M shares |
| 5 years | -11% | -322M shares |
| Available history | -17% | -547M shares |
JPM has the edge over CCNE on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $1.1B |
| Q2 2026 | $6.8B |
| Q1 2026 | $8.3B |
| Q4 2025 | $8.3B |
| Q3 2025 | $8.3B |
| Q2 2025 | $7.5B |
| Q1 2025 | $7.5B |
| Q4 2024 | $4.3B |
JPM spent $24.5B buying back its own shares over the past year, down 11% from the year before.
CCNE Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -0.8x | Net Cash |
| Q2 2026 | -1.9x | Net Cash |
| Q1 2026 | -3.1x | Net Cash |
| Q4 2025 | -3.0x | Net Cash |
| Q3 2025 | -2.5x | Net Cash |
| Q2 2025 | -4.5x | Net Cash |
| Q1 2025 | -5.8x | Net Cash |
| Q4 2024 | -4.7x | Net Cash |
CCNE has the edge over JPM on leverage, with a lower net debt burden relative to earnings.
JPM Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.5x | Very low |
| Q2 2026 | 0.5x | Very low |
| Q1 2026 | 0.6x | Very low |
| Q4 2025 | 0.5x | Very low |
| Q3 2025 | 0.6x | Very low |
| Q2 2025 | 0.5x | Very low |
| Q1 2025 | 0.5x | Very low |
| Q4 2024 | 0.4x | Very low |
JPM's net debt is less than a year of its operating earnings (EBITDA). Net leverage isn't a meaningful measure for financial services companies like JPM.
CCNE Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 64.7 | Neutral |
| Stochastic | 66.7 | Neutral |
CCNE's weekly RSI is 65 (neutral) and its Stochastic is 67 (neutral).
JPM Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 54.8 | Neutral |
| Stochastic | 31.5 | Neutral |
JPM's weekly RSI is 55 (neutral) and its Stochastic is 31 (neutral).
CCNE PE vs Financial Services Sector
| Metric | CCNE | Sector median | Relative |
|---|---|---|---|
| PE | 11x | 13x | 19% below |
| PE % | 71 | 63 | 8 pts above |
CCNE has the edge over JPM on valuation relative to its sector.
JPM PE vs Financial Services Sector
| Metric | JPM | Sector median | Relative |
|---|---|---|---|
| PE | 14x | 13x | 10% above |
| PE % | 76 | 63 | 13 pts above |
JPM is trading at 14x earnings, a 10% premium to the Financial Services sector's median of 13x.
CCNE Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $34.7 | 2.6% above |
| 20 week MA | $34.5 | 3.3% above |
| 50 week MA | $31.3 | 14% above |
| 100 week MA | $27.6 | 29% above |
| 200 week MA | $24.3 | 47% above |
CCNE has the edge over JPM on trend strength, trading above more of its moving averages.
JPM Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $336.8 | 1.8% above |
| 20 week MA | $345.3 | 0.7% below |
| 50 week MA | $323.2 | 6.1% above |
| 100 week MA | $298.9 | 15% above |
| 200 week MA | $236.6 | 45% above |
JPM's trend is mixed: it's above four of its five weekly moving averages, and 45% above its 200-week average.
CCNE Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $32.8 | $20.9 | -36% |
| 2021 | $20.9 | $26.7 | +28% |
| 2022 | $26.7 | $24.1 | -9.7% |
| 2023 | $24.1 | $22.6 | -6.3% |
| 2024 | $22.6 | $24.9 | +10% |
| 2025 | $24.9 | $26.8 | +7.7% |
| 2026 YTD | $26.8 | $35.6 | +33% |
CCNE has the edge over JPM on returns for 2026, with the stronger performance.
JPM Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $139.1 | $124.5 | -11% |
| 2021 | $124.5 | $157.3 | +26% |
| 2022 | $157.3 | $131.3 | -17% |
| 2023 | $131.3 | $170.1 | +30% |
| 2024 | $170.1 | $241.2 | +42% |
| 2025 | $241.2 | $327.9 | +36% |
| 2026 YTD | $327.9 | $342.8 | +4.5% |
JPM has finished higher in four of the last six years. It's up 4.5% so far in 2026.